Category: Finance
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
Memphasys drops 30pc after trial results disappoint investors Echo IQ licences its cardio decision-support tool, EchoSolv, to Respiri Truscreen’s sales up 40pc in Q3 [more…]
Neurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soon
Neurotech views lead drug NTI164 as a promising, cost-effective and long-term treatment for ASD Health economic consultancy appointed to evaluate economic benefits of treating ASD [more…]
Western Yilgarn looking to expand Bulga footprint via potential JV with Fleet Street
Western Yilgarn has entered into a binding JV term sheet with Fleet Street Holdings for rights to access four tenements The four tenements provide the [more…]
Top 10 at 10: Data stock on the rise as Domino’s gets burnt, cattle inseminator shoots blanks
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
FMG Results: Iron Bridge ramp up continues to stutter but the tried and tested works wonders for FMG
Fortescue knocks down guidance again at Iron Bridge as issues with a leaking water pipeline persist But its realisations for low grade iron ore were [more…]
Australian Mines’ new Brazilian REE target has all the ingredients for a succulent fry-up
Australian Mines identifies high-priority target for follow-up exploration at the Jequie REE project in Brazil The target contains a 30km long by up to 2.5km [more…]
Market Highlights: Netflix fuels tech rally, the bullish case for iron ore, and 5 ASX small caps to watch
ASX to climb higher after a tech rally in New York Netflix climbed after posting solid quarterly figures And experts give their outlook on iron [more…]
Skin in the game: Which directors are buying the lithium dip?
Global Lithium Resources and Minerals 260 see directors pony up for more shares as lithium prices fall Alkane Resources chairman Ian Gandel makes a $5 [more…]
Weed Week: Medicinal cannabis will be here no matter what; and recent ASX pot winners
Key focus for cannabis in 2024 is still the US DEA’s potential rescheduling Whether or not that happens, medicinal cannabis will always play a part [more…]
Can you dig it? We’ve unearthed the best value miners from across Morningstar’s entire universe
Right now, it’s the gold and thermal coal companies which feature heavily among the world’s cheapest, according to Morningstar mining analyst Jon Mills. But before [more…]
